InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (6 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
6
T+90 hit rate
33%
T+90 mean return
-0.2%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by De Witte Jan, Director. Officer active across 2 companies, notably RESMED INC. Aggregated, 22 reports have been recorded. Breakdown: 1 buy · 6 sells. Total volume traded: €1.6m. History available since 11 November 2021. The latest transaction was filed on 25 November 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations22 total
2,055 shares@ US$255.0033.8% of flowReMed Common StockSEC:0000943819-25-000181:0
1,073 shares0ReMed Common StockSEC:0000943819-25-000166:0
487 shares@ US$250.2511.8% of flowReMed Common StockSEC:0000943819-25-000115:0
2,000 shares@ US$243.4753.4% of flowReMed Common StockSEC:0001127602-25-015264:0
1,083 shares0ReMed Common StockSEC:0001127602-24-027902:0
796 shares@ US$248.8123.0% of flowReMed Common StockSEC:0001127602-24-027277:0
9,814 shares0Common StockSEC:0000917520-24-000109:0
360 shares@ US$218.298.9% of flowReMed Common StockSEC:0001127602-24-016231:0
360 shares@ US$218.298.9% of flowReMed Common StockSEC:0001127602-24-015777:0
205 shares0Common StockSEC:0000917520-24-000037:0
346 shares0Common StockSEC:0000917520-24-000025:0
597 shares0Common StockSEC:0000917520-24-000002:0
1,768 shares0ReMed Common StockSEC:0001127602-23-028090:0
9,814 shares0Common StockSEC:0001209191-23-054323:0
205 shares0Common StockSEC:0001209191-23-052775:0
7,792 shares@ US$38.499259.2% of flowCommon StockSEC:0001209191-23-033676:0
Ideal exit: 26 Feb 2024 (T+270)
3,842 shares@ US$52.8740.8% of flowCommon StockSEC:0001209191-23-018446:0
8,848 shares0Common StockSEC:0001209191-23-009758:0
431 shares0Common StockSEC:0001209191-23-004012:0
1,122 shares0ReMed Common StockSEC:0001127602-22-026159:0
956 shares0ResMed Common StockSEC:0000943819-21-000034:0
104 shares@ US$259.470.0001% mcap50.0% of flowReMed Common StockSEC:0001127602-21-029093:0
22 of 22 declarations
About De Witte Jan
Jan De Witte is a Director at ResMed Inc. As a board member, he participates in the governance of the company and the development of its strategy. ResMed Inc. is a company specializing in health technologies, particularly solutions for respiratory disorders. De Witte leverages his expertise to help steer the company toward new growth opportunities and improve the quality of healthcare.
